Translation. Region: Russian Federal
Source: People's Republic of China in Russian – People's Republic of China in Russian –
An important disclaimer is at the bottom of this article.
Source: People's Republic of China – State Council News
BEIJING, July 24 (Xinhua) — China's medical insurance funds' spending on new drugs, or innovative medicines purchased through government procurement following price negotiations with pharmaceutical companies, increased by an average of 40 percent annually during the 14th Five-Year Plan period (2021-2025), Zhang Ke, director general of the National Medical Security Administration, said Thursday.
In 2024, the expenditure of health insurance funds on purchasing new drugs through price negotiations increased by 3.9 times compared with the figure in 2020. During the 14th Five-Year Plan period, the total expenditure of China's health insurance funds reached 12.13 trillion yuan (about 1.7 trillion US dollars), with an average annual increase of 9.1 percent, Zhang Ke said at a press conference. -0-
Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.
.